Trinity Capital announced the commitment of $15 million in growth capital to restor3d, a 3D printing, patient specific medical device company. The new debt facility from Trinity will allow restor3d to continue its product innovation and expansion into new markets.

restor3d enhances patient care and meets surgeons' needs by providing solutions tailored to patients' unique anatomies, enabling precise repair, reconstruction, and restoration. The company holds proprietary expertise in advanced 3D printing of osseointegrative materials, AI-based planning and design automation tools, and digital health solutions to provide seamless data-backed care to optimize individual patient outcomes.

"restor3d is at the forefront of innovation in the customized orthopedic implant industry with its unique patient specific 3D printed technologies," said Lauren Cosentino, Managing Director, Life Sciences at Trinity. "We look forward to working with restor3d's leadership team and supporting the company's continued growth."

"We are thrilled to partner with Trinity as we continue to scale our business and bring our innovative, patient specific medical devices to more surgeons and patients worldwide," said Kurt Jacobus, Chief Executive Officer of restor3d. "This investment underscores the immense potential of our technology to transform patient care and drive better surgical outcomes."